Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Huperzine A for Cognitive Deficits After TBI
NCT01676311Phase 2Terminated
- Sponsor
- Spaulding Rehabilitation Hospital
- Start
- Dec 2013
- Primary completion
- Aug 2018
- Modality
- Nucleic Acid-Directed Small Molecules, Covalent Small Molecules, Classical Binding Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Huperzine A in traumatic brain injury (TBI), sponsored by Spaulding Rehabilitation Hospital. Started Dec 2013; status: terminated.
02
Drugs
Huperzine A
03
Conditions
traumatic brain injury (TBI)
Beyond the preview
Go deeper on NCT01676311.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01676311.